Replies to post #269271 on Amarin Corp Plc (AMRN)

[dockside130]

Physicians don’t usually choose what generic is dispensed. The pharmacy or drug benefit company controls this.

[north40000]

Amarin NOW should be MOST concerned about massive numbers of DTC ads on network TV and newspapers re other drugs being effective to treat heart disease, e.g., LLY Jardiance ads. There are other companies with similar ads for their drugs. These ads could slow uptake of Vascepa in the minds of M.D.s not yet educated about Vascepa and its lower cost while achieving better results of reducing risks in patients with CVDs and T2- diabetes.

I have yet to see LLY advertising Jardiance reduces risk of CVDs in COV-19 patients. AMRN isn’t either, but is “looking” at that potential for Vascepa.